These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11003027)
1. Gene therapy with angiogenic factors for the treatment of ischemic diseases. Melillo G; Capogrossi MC Ital Heart J; 2000 Sep; 1 Suppl 3():S59-60. PubMed ID: 11003027 [No Abstract] [Full Text] [Related]
2. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials. Ylä-Herttuala S; Markkanen JE; Rissanen TT Trends Cardiovasc Med; 2004 Nov; 14(8):295-300. PubMed ID: 15596105 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Losordo DW; Dimmeler S Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038 [No Abstract] [Full Text] [Related]
4. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in the human heart: gene and cell therapy. Tirziu D; Simons M Angiogenesis; 2005; 8(3):241-51. PubMed ID: 16308736 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis. Devising new strategies based on past experiences. Lei Y; Haider HKh; Shujia J; Sim ES Basic Res Cardiol; 2004 Mar; 99(2):121-32. PubMed ID: 14963670 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II. Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823 [TBL] [Abstract][Full Text] [Related]
9. Endothelial dysfunction--an obstacle of therapeutic angiogenesis. Sun L; Bai Y; Du G Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489 [TBL] [Abstract][Full Text] [Related]
10. Prospects for therapeutic angiogenesis and myogenesis in patients with advanced coronary disease. Ellis SG; Cura FA; Mukherjee D J Invasive Cardiol; 1999 Oct; 11(10):615-7. PubMed ID: 10745443 [No Abstract] [Full Text] [Related]
11. A balancing act: therapeutic approaches for the modulation of angiogenesis. Springer ML Curr Opin Investig Drugs; 2006 Mar; 7(3):243-50. PubMed ID: 16555684 [TBL] [Abstract][Full Text] [Related]
12. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of gene therapy with transforming growth factor-beta or extracorporal shock wave therapy to reduce ischemic necrosis in an epigastric skin flap model in rats. Huemer GM; Meirer R; Gurunluoglu R; Kamelger FS; Dunst KM; Wanner S; Piza-Katzer H Wound Repair Regen; 2005; 13(3):262-8. PubMed ID: 15953045 [TBL] [Abstract][Full Text] [Related]
15. Angiogenic and antiangiogenic gene therapy. Malecki M; Kolsut P; Proczka R Gene Ther; 2005 Oct; 12 Suppl 1():S159-69. PubMed ID: 16231050 [TBL] [Abstract][Full Text] [Related]